Gleason 7  

Donate to PCRI: pcri.org/donate/
For more information, visit pcri.org
0:28 Is the monitoring process for a Gleason 3+3 different than for Gleason 3+4?
2:13 Does the location of Gleason 7 cancer eliminate the use of brachytherapy?
4:12 Can focal treatment be considered if the tumor might have breached the prostatic capsule?
5:14 Is there a preferred method of focal therapy for a breached tumor?
6:20 After radiation treatment and ADT with an undetectable PSA can hormone therapy be stopped?
7:28 74 years old, Gleason 3+4, PSA 25, doctors want treatment. Is it necessary?
9:11 58 years old, PSA 10.8, Gleason 3+4, PET PSMA scans negative. Do I need treatment?
12:22 How should genetic testing be used as a diagnostic tool?
14:08 With a PSA of 10.3, Gleason 3+4 is a CT/Bone scan a good idea?
15:50 With a 1.75 cc lesion 10% Gleason 4 as it grows will the cells stay the same?
17:25 With a Gleason 3+4 diagnosis, low testosterone, is adding low dose testosterone ok?
19:31 Alex's conclusions
21:53 If you need more help
Don't know your stage? Take the quiz: visit www.prostatecan...
To learn more about prostate cancer, visit www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.